KLACID GRANULES FOR ORAL SUSPENSION 250 mg5 ml Singapore - English - HSA (Health Sciences Authority)

klacid granules for oral suspension 250 mg5 ml

abbott laboratories (singapore ) private limited - clarithromycin - granule, for suspension - 250 mg/5 ml - clarithromycin 250 mg/5 ml

KLACID GRANULES FOR ORAL SUSPENSION 125 mg5 ml Singapore - English - HSA (Health Sciences Authority)

klacid granules for oral suspension 125 mg5 ml

abbott laboratories (singapore ) private limited - clarithromycin - granule, for suspension - 125 mg/5 ml - clarithromycin 125 mg/5 ml

KLACID MR TABLET 500 mg Singapore - English - HSA (Health Sciences Authority)

klacid mr tablet 500 mg

abbott laboratories (singapore ) private limited - clarithromycin - tablet, extended release - 500 mg - clarithromycin 500 mg

KLACID FORTE TABLET 500 mg Singapore - English - HSA (Health Sciences Authority)

klacid forte tablet 500 mg

abbott laboratories (singapore ) private limited - clarithromycin - tablet, film coated - 500 mg - clarithromycin 500 mg

KLACID TABLET 250 mg Singapore - English - HSA (Health Sciences Authority)

klacid tablet 250 mg

abbott laboratories (singapore ) private limited - clarithromycin - tablet, film coated - 250 mg - clarithromycin 250 mg

Klacid New Zealand - English - Medsafe (Medicines Safety Authority)

klacid

viatris limited - clarithromycin 25 mg/ml;  ;   - granules for oral suspension - 125 mg/5ml - active: clarithromycin 25 mg/ml     excipient: carbomer castor oil citric acid monohydrate fruit mix flavour wl-18758 204264 hydrated silica hypromellose phthalate maltodextrin potassium sorbate povidone sucrose titanium dioxide xanthan gum - klacid suspension is indicated for treatment of infections caused by susceptible organisms. such infections include: ? upper respiratory infections (e.g. streptococcal pharyngitis). ? lower respiratory infections (e.g. bronchitis, pneumonia). ? acute otitis media. ? skin and skin structure infections (e.g. impetigo, folliculitis, cellulitis, abscesses). ? disseminated or localized mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare. localised infections due to mycobacterium chelonae, mycobacterium fortuitum or mycobacterium kansasii.

Clarithromycin Inresa 500 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

clarithromycin inresa 500 mg pulver für ein konzentrat zur herstellung einer infusionslösung

KLACID SR TABLETS Israel - English - Ministry of Health

klacid sr tablets

abbott medical laboratories ltd, israel - clarithromycin - tablets slow release - clarithromycin 500 mg - clarithromycin - clarithromycin - for treatment of infections caused by susceptible organisms. for lower respiratory tract infections, upper respiratory tract infections, skin and soft tissue infections

KLACID PAEDIATRIC SUSPENSION 125 MG5 ML Israel - English - Ministry of Health

klacid paediatric suspension 125 mg5 ml

abbott medical laboratories ltd, israel - clarithromycin - granules for reconstitution - clarithromycin 125 mg / 5 ml - clarithromycin - clarithromycin - bronchitis, pharyngitis, tonsilitis pneumonia skin infections due to susceptible microorganisms. treatment of mycobacterium avium complex in patients with aids. treatment of otitis media.

Klacid Forte 500 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

klacid forte 500 mg film-coated tablets

pco manufacturing ltd. - clarithromycin - film-coated tablet - 500 milligram(s) - macrolides; clarithromycin